Mariner’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-40,004
Closed -$74.8K 3750
2025
Q4
$74.8K Buy
40,004
+28,608
+251% +$55K ﹤0.01% 3369
2025
Q3
$14.6K Sell
11,396
-4,030
-26% -$5.46K ﹤0.01% 3525
2025
Q2
$19.1K Sell
15,426
-1,431
-8% -$1.65K ﹤0.01% 3425
2025
Q1
$19.9K Sell
16,857
-12,907
-43% -$19.8K ﹤0.01% 3381
2024
Q4
$54.5K Buy
29,764
+118
+0.4% +$230 ﹤0.01% 3278
2024
Q3
$50.4K Sell
29,646
-8,445
-22% -$13.9K ﹤0.01% 3192
2024
Q2
$52.2K Buy
38,091
+16,640
+78% +$33.6K ﹤0.01% 3052
2024
Q1
$80.4K Buy
21,451
+10,090
+89% +$59.1K ﹤0.01% 2967
2023
Q4
$111K Buy
11,361
+416
+4% +$3.4K ﹤0.01% 2838
2023
Q3
$91.4K Buy
+10,945
New +$125K ﹤0.01% 2691
2021
Q1
Sell
-53,775
Closed -$1.4M 881
2020
Q4
$1.4M Sell
53,775
-99,972
-65% -$1.7M 0.01% 499
2020
Q3
$1.52M Sell
153,747
-50,000
-25% -$288K 0.01% 420
2020
Q2
$703K Hold
203,747
0.01% 546
2020
Q1
$623K Buy
+203,747
New +$834K 0.01% 548

Other funds holding PACB